Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Moonlit Cannabis is a California-based cannabis brand that specializes in products designed to support sleep and nighttime relaxation. The brand was developed to address the growing consumer demand for functional cannabis products, specifically targeting the sleep-aid market. Its product portfolio includes premium flower and pre-rolls that utilize specific cannabinoid ratios, often emphasizing the sedative properties of Cannabinol (CBN) in combination with THC. Originally a proprietary brand of The Parent Company (TPCO Holding Corp), Moonlit is now part of the Gold Flora Corporation following a 2023 merger. The company focuses on high-quality cultivation and precise formulation to ensure consistent effects for users seeking natural alternatives to traditional sleep medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Moonlit Cannabis.